| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V0436 | AGK2 | 304896-28-4 | AGK2 is a novel, potent, and selective inhibitor of SIRT2 (sirtuin 2, histone deacetylase) with potential anti-inflammatory activity. |
|
V131820 | Citriniorl A | Citriniorl A is a SIRT1 enhancer with an EC50 value of 5.8 μM. | |
|
V133346 | DDL-218 | 2767324-34-3 | DDL-218 is an orally effective and potent SirT1 inhibitor. |
|
V141296 | NH4-6 | 2375182-58-2 | NH4-6 is a SIRT2 inhibitor with an IC50 value of 0.032 μM for SIRT2 and 3 μM for SIRT1. |
|
V3140 | OSS-128167 | 887686-02-4 | OSS_128167 (formerly SIRT6-IN-1) is a novel, potent and selectiveSIRT6inhibitor withIC50 of 89, 1578 and 751 μM for SIRT6, SIRT1 and SIRT2, respectively. |
|
V55738 | Selaginellin | 941269-84-7 | Selaginellin is an inhibitor (blocker/antagonist) of Reactive Oxygen Species and an activator of SIRT1. |
|
V0429 | Selisistat (SEN0014196; EX 527) | 49843-98-3 | Selisistat (formerly SEN-0014196; EX-527) is a novel, highlypotent and selective inhibitor of SIRT1 (Sirtuin1, aNAD-dependent and class III histone deacetylase enzyme) with important biological activity. |
|
V0439 | SirReal2 | 709002-46-0 | SirReal2 is a novel, highly potent and isoform-selective inhibitor of Sirt2 (Sirtuin 2) with potential anticancer and anti-inflammatory activity. |
|
V106893 | SIRT-IN-6 | 1431411-18-5 | SIRT-IN-6 (Compound 14) is a pan-inhibitor of SIRT1/2/3 with IC50 value >50 μM. |
|
V144973 | SIRT1 activator 4 | 1049800-47-6 | SIRT1 activator 4 is an orally effective, NAD+-independent SIRT1 activator. |
|
V144974 | Sirt1/2-IN-5 | 143034-06-4 | Sirt1/2-IN-5 is a SIRT1/SIRT2 inhibitor with an IC50 value of 0.3 μM for human SIRT1, an IC50 value of 1.2 μM for human SIRT2, and a pIC50 value of 5.82. |
|
V88781 | SIRT2-IN-15 | 312275-43-7 | SIRT2-IN-15 (compound 1) is a SIRT2 sirtuin and deamylase inhibitor with IC50 of 7 and 37 μM, respectively. |
|
V94618 | SIRT6 activator 2 | 2867630-96-2 | SIRT6 activator 2 (compound 31) is a sirtuin 6 activator with anti-lipid accumulation properties. |
|
V144976 | SIRT6 activator 3 | SIRT6 activator 3 is a SIRT6 activator with an EC50 value of 5 μM. | |
|
V144979 | Sirtuin modulator 8 | 925437-38-3 | Sirtuin modulator 8 is a Sirtuin modulator that can activate Sirtuin activity. |
|
V111099 | Sirtuin-IN-1 | 1392810-44-4 | Sirtuin-IN-1 (compound 18) is a SIRT1/2 inhibitor (IC50 values of 6.2 μM and 4.2 μM for SIRT1 and SIRT2, respectively). |
|
V145016 | SKLB-11A | 433953-86-7 | SKLB-11A is a selective, orally effective allosteric SIRT3 (sirtuin 3) agonist with a Kd value of 4.7 μM. |
|
V4054 | SRT1720 | 925434-55-5 | SRT1720 (formerly known as CAY10559) is a novel and selective SIRT1 activator with an EC50 of 0.16 μM in a cell-free assay, but is >230-fold less potent for SIRT2 and SIRT3. |
|
V0428 | SRT1720 HCL (CAY-10559) | 1001645-58-4 | SRT1720 HCl (formerly known as CAY10559 HCl), the hydrochloride salt ofSRT1720, is a novel, potent and selective SIRT1(Sirtuin 1) activator with potential anticancer activity and isa promising new therapeutic agent for treating type 2 diabetes. |
|
V0438 | SRT2104 (GSK-2245840) | 1093403-33-8 | SRT2104 (formerly GSK-2245840; SRT2104;GSK2245840;SRT-2104) is a novel, first-in-class, brain penetrant, and highly selective small molecule activator of SIRT1 (Sirtuin 1) with potential use forneurodegenerative diseases. |